Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia
| Autor: | DeAngelo, Daniel J. *, Jonas, Brian A., Liesveld, Jane L., Bixby, Dale L., Advani, Anjali S., Marlton, Paula, Magnani, John L., Thackray, Helen M., Feldman, Eric J., O'Dwyer, Michael E., Becker, Pamela S. |
|---|---|
| Zdroj: | In Blood 24 February 2022 139(8):1135-1146 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|